Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Journal of Pharmacology and Toxicology
  Year: 2017 | Volume: 12 | Issue: 4 | Page No.: 170-179
DOI: 10.3923/jpt.2017.170.179
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Assessment of Toxicity of Myristicin and 1’-Hydroxymyristicin in HepG2 Cell Line

Laura Marabini , Laura Neglia, Erika Monguzzi, Corrado L. Galli and Marina Marinovich

Abstract:
Background and Objective: Myristicin belongs to a class of potentially toxic chemicals (alkoxy substituted allylbenzenes) and despite the structural analogy with safrole, data on this compound are very controversial and unclear. In this study assessed the cytotoxic and genotoxic potential of myristicin and 1’-hydroxy-myristicin after 24 h of exposure in HepG2 cells. Methodology: The compounds were tested up to 600 μM concentration, for 24 h. The genotoxicity was assessed with alkaline and neutral comet assay and micronucleus assay. The data were analysed by one-way ANOVA. Results: It is to be emphasized that only the synthetic Phase 1 metabolite (1’-hydroxymyristicin) showed a genotoxic effect starting from the concentration of 150 μM both in comet and micronucleus tests. However, it is important to point out that the same concentration cause a statistically significant (p<0.001) apoptotic process. Conclusion: The consumption of a traditional diet determines very low levels of exposure to the parent myristicin. This fact implies as the primary metabolic pathway the O-demethylation (5-allyl-2,3-dihidroxyanisole) and not to Phase I metabolism, which leads to the conclusion that this substance could not present a significant risk to humans.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Laura Marabini, Laura Neglia, Erika Monguzzi, Corrado L. Galli and Marina Marinovich, 2017. Assessment of Toxicity of Myristicin and 1’-Hydroxymyristicin in HepG2 Cell Line. Journal of Pharmacology and Toxicology, 12: 170-179.

DOI: 10.3923/jpt.2017.170.179

URL: https://scialert.net/abstract/?doi=jpt.2017.170.179

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom